Therapeutic agent for dyskinesia
Details for Australian Patent Application No. 2006234627 (hide)
International Classifications
Event Publications
8 November 2007 Amendment Made
The nature of the amendment is: Amend the invention title to read Therapeutic agent for dyskinesia
15 November 2007 PCT application entered the National Phase
PCT publication WO2006/109876 Priority application(s): WO2006/109876
11 June 2009 Application Accepted
Published as AU-B-2006234627
6 August 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 16 Jul 2009. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000
26 November 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 16 Jul 2009
3 December 2009 Standard Patent Sealed
3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006234618-Pyrazolo(1,5-a)pyridine derivative or medically acceptable salt thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser